臂丛神经阻滞中加入地塞米松如何改变桡骨远端骨折术后疼痛模式?一项随机双盲研究
该随机双盲试验纳入69例超声引导下锁骨上臂丛神经阻滞下掌侧钢板固定桡骨远端骨折患者,比较加入地塞米松5 mg与不加地塞米松的差异。结果显示地塞米松组仅在术后8小时疼痛评分有临床重要差异,且阻滞持续时间延长约3小时,但芬太尼用量和止吐药使用无组间差异;术后即刻血糖地塞米松组较高。
要点
- 地塞米松组术后8小时VAS疼痛评分低于非地塞米松组,差异有临床意义。
- 地塞米松组臂丛神经阻滞持续时间较非地塞米松组延长约3小时。
- 两组芬太尼用量和止吐药使用无显著差异,地塞米松组术后即刻血糖较高。
核心结论
- 在桡骨远端骨折掌侧钢板固定术中,区域阻滞加入地塞米松者的术后疼痛水平与常规臂丛阻滞者无临床差异,但地塞米松组阻滞轻度延长且术后8小时疼痛减轻。
研究设计与样本
- 随机双盲试验纳入69例在超声引导下锁骨上臂丛神经阻滞下行桡骨远端骨折手术的患者,随机分为非地塞米松组(0.5%罗哌卡因)和地塞米松组(0.5%罗哌卡因加5 mg地塞米松)。
- 地塞米松组分配34例,非地塞米松组分配35例;随机化后排除9例(地塞米松组4例,非地塞米松组5例),因阻滞不全术中改用局麻药或术后要求患者自控镇痛。
主要发现
- 术后8小时VAS疼痛评分地塞米松组为1.9 ± 1.6,非地塞米松组为4.7 ± 2.7,平均差-2.8(95% CI -3.9至-1.6),p < 0.001。
- 芬太尼用量地塞米松组为21 ± 38 mcg,非地塞米松组为31 ± 29 mcg,平均差-10(95% CI -27.4至7.4),p = 0.26。
- 止吐药使用率地塞米松组为27%(8/30),非地塞米松组为37%(11/30),比值比1.6(95% CI 0.5至4.8),p = 0.41。
- 术后即刻血糖地塞米松组为121 ± 29,非地塞米松组为104 ± 20,平均差16(95% CI 3.3至28.8),p = 0.02;术前和术后24小时血糖无组间差异。
- 臂丛神经阻滞持续时间地塞米松组为11 ± 5小时,非地塞米松组为8 ± 3小时,地塞米松组延长3小时(95% CI 0.8至5.2小时),p = 0.01。
关键数值与推荐
- 主要结局为术后4、8、12、24和48小时用10-mm VAS评估的疼痛,VAS最小临床重要差异为2/10分。
- 次要结局包括芬太尼补救镇痛、因芬太尼使用而接受止吐药的患者数以及臂丛神经阻滞持续时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although brachial plexus block in volar plating surgery for distal radius fractures is reportedly associated with lower postoperative pain scores, rebound pain has been reported to occur after the initial block wears off. Dexamethasone can be used in multimodal strategies for antiemesis and to control pain postoperatively. Although prior studies have suggested that anesthesia can be prolonged by adding dexamethasone to regional blocks, no randomized trials we are aware of have ascertained whether doing so will make a clinically important difference in pain after surgery for distal radius fractures. QUESTIONS/PURPOSES: Do patients who receive supplemental dexamethasone in a brachial plexus block for volar plating of unstable distal radius fractures have (1) better pain scores at 4, 8, 24, and 48 hours postoperatively than patients who have not received dexamethasone, and (2) lower fentanyl consumption and administration of antiemetic drugs without change in serum blood glucose, as well as a longer analgesic duration from the block after surgery than patients who have not received dexamethasone? METHODS: This randomized, double-blind trial included 69 patients undergoing surgery for distal radius fractures under ultrasound-guided supraclavicular brachial plexus blocks who were randomly allocated into two groups: a nondexamethasone group receiving a brachial plexus block with 0.5% ropivacaine and a dexamethasone group receiving 0.5% ropivacaine and 5 mg of dexamethasone. Thirty-four patients were allocated to the dexamethasone group and 35 were allocated to the nondexamethasone group. Nine patients (four in the dexamethasone group and five in the nondexamethasone group) were excluded after randomization because local anesthetics were used during their surgical procedures owing to an incomplete block or they requested patient-controlled analgesia after surgery. The treatment groups did not differ in any important ways, including age, gender, BMI, hand dominance, and AO/Orthopaedic Trauma Association classification. All patients received the same surgical procedure and perioperative care protocol, except for the injected agents during their brachial plexus block. The primary outcome was postoperative pain, evaluated using a 10-mm VAS at 4, 8, 12, 24, and 48 hours after surgery. The minimum clinically important difference for the VAS score was 2 of 10 points. Secondary outcome variables included fentanyl administration as a rescue analgesic, the number of patients receiving antiemetic medications because of fentanyl administration, and the duration of brachial plexus block. Serum blood glucose was measured 1 day before, immediately after, and 24 hours after surgery. Patients, surgeons, and outcome assessors were blinded to treatment allocation. RESULTS: The only clinically important between-group difference in VAS pain scores was at 8 hours, favoring the group that received dexamethasone over the group that did not (1.9 ± 1.6 versus 4.7 ± 2.7; mean difference -2.8 [95% CI -3.9 to -1.6]; p < 0.001). After brachial plexus block, the most severe pain score in both groups was reported at 12 hours postoperatively and gradually diminished over time. There was no between-group difference in fentanyl use between those who received dexamethasone and those who did not (21 ± 38 mcg versus 31 ± 29 mcg; mean difference -10 [95% CI -27.4 to 7.4]; p = 0.26). Furthermore, the use of antiemetics did not differ between the groups (27% [eight of 30] versus 37% [11 of 30]; odds ratio 1.6 [95% CI 0.5 to 4.8]; p = 0.41). Baseline and 24-hour postoperative serum blood glucose level did not differ between the groups. However, the immediately postoperative serum blood glucose level was higher in the dexamethasone group than in the nondexamethasone group (121 ± 29 versus 104 ± 20; mean difference 16 [95% CI 3.3 to 28.8]; p = 0.02). The brachial plexus block duration was 3 hours longer (95% CI 0.8 to 5.2 hours) in the dexamethasone group than that in the nondexamethasone group (11 ± 5 hours versus 8 ± 3 hours; p = 0.01). CONCLUSION: The postoperative pain level in patients who received supplemental dexamethasone in a regional block was not clinically different from that of patients who received conventional brachial plexus block anesthesia when undergoing volar plating for distal radius fractures. However, patients who received a brachial plexus block with dexamethasone experienced slight prolongation of their block and decrease in pain 8 hours after surgery. LEVEL OF EVIDENCE: Level I, therapeutic study.
引用
- Kim MK, Park YH, Lee JS, et al. How Does the Addition of Dexamethasone to a Brachial Plexus Block Change Pain Patterns After Surgery for Distal Radius Fractures? A Randomized, Double-blind Study. Clin Orthop Relat Res. 2023. PMID: 37053082. doi:10.1097/CORR.0000000000002640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。